• CONTACT
  • ABOUT US
  • NEWS & MEDIA
  • UPCOMING EVENTS
  • Canady Helios Cold Plasma
  • Canady Hybrid Plasma
    • Canady Hybrid Plasma Technology
    • Canady Plasma XL 1000 Smart Electrosurgical Generator
    • Canady Hybrid Plasma™ Scalpel
    • Canady Plasma Probes
  • Our Treatment
  • Science of Plasma
  • Publications
  • Our Patients
    • PATIENT FOCUS
    • Clinical Trial

Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins

by PVA_Admin | Dec 11, 2025 | Feature

Published: 2 December 2025 Saravana R. K. Murthy, Taisen Zhuang, Olivia Z. Jones, Yasmine Dakak, Michael Keidar, Aviram Nissan, and Jerome Canady.  Residual tumor cells left behind after surgery are a major cause of cancer local recurrence. The Canady Helios Cold...
Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins

Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins

by PVA_Admin | Dec 2, 2025 | Cold Plasma Publications, Publications

Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins Saravana R. K. Murthy, Taisen Zhuang, Olivia Z. Jones, Yasmine Dakak, Michael Keidar, Aviram Nissan, and Jerome...
Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins

The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer

by PVA_Admin | Jul 20, 2023 | Cold Plasma Publications, Publications

The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer Jerome Canady, Saravana R. K. Murthy, Taisen Zhuang, Steven Gitelis, Aviram Nissan, Lawan Ly, Olivia Z. Jones, Xiaoqian Cheng,...
Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report

Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report

by PVA_Admin | Jun 16, 2022 | Cold Plasma Publications, Publications

Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report Lawan Ly, Xiaoqian Cheng, Saravana R. K. Murthy, Olivia Z. Jones, Taisen Zhuang, Steven Gitelis, Alan T....
The Granger Causal Effects of Canady Helios Cold Plasma on the Inhibition of Breast Cancer Cell Proliferation

The Granger Causal Effects of Canady Helios Cold Plasma on the Inhibition of Breast Cancer Cell Proliferation

by PVA_Admin | May 5, 2022 | Cold Plasma Publications, Publications

The Granger Causal Effects of Canady Helios Cold Plasma on the Inhibition of Breast Cancer Cell Proliferation Annisa Elbedour, Xiaoqian Cheng, Saravana R. K. Murthy, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, and Jerome Canady Cold...
BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer

BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer

by PVA_Admin | Mar 8, 2022 | Cold Plasma Publications, Publications

BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer Saravana R. K. Murthy, Xiaoqian Cheng, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, & Jerome Canady Breast cancer is the most common cause...
« Older Entries

Recent Posts

  • Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins
  • Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins
  • US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
  • USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
  • Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”

Recent Comments

No comments to show.

CANADY HELIOS COLD PLASMA ›

CANADY HYBRID PLASMA ›

OUR TREATMENT ›

SCIENCE OF PLASMA ›

ABOUT US ›

OUR PATIENTS ›

NEWS & MEDIA ›

CONTACT USMI ›

Copyright © 2025 US Medical Innovations